Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
42.45 M
About Kaleido Biosciences, Inc.
Kaleido Biosciences, Inc. is a clinical-stage healthcare company, which engages in the provision of healthcare services. It focuses on leveraging the microbiome organ to treat disease and improve human health. The firm offers microbiome metabolic therapies (MMT), which are designed to modulate the metabolic output and profile of the microbiome by driving the function and composition of the organ's existing microbes. The company was founded by Geoffrey von Maltzahn and Noubar B. Afeyan on January 27, 2015 and is headquartered in Lexington, MA.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of KLDO is 0.000100 USD — it has increased by 9.90 K% in the past 24 hours. Watch Kaleido Biosciences, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Kaleido Biosciences, Inc. stocks are traded under the ticker KLDO.
KLDO stock hasn't changed in a week, the last month showed zero change in price, over the last year there was no change in Kaleido Biosciences, Inc. price.
KLDO reached its all-time high on Jan 28, 2021 with the price of 20.500000 USD, and its all-time low was 0.000001 USD and was reached on May 9, 2023. View more price dynamics on KLDO chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
KLDO stock is 99.00% volatile and has beta coefficient of 400.70. Track Kaleido Biosciences, Inc. stock price on the chart and check out the list of the most volatile stocks — is Kaleido Biosciences, Inc. there?
Today Kaleido Biosciences, Inc. has the market capitalization of 4.26 K, it has decreased by −98.99% over the last week.
Yes, you can track Kaleido Biosciences, Inc. financials in yearly and quarterly reports right on TradingView.
Kaleido Biosciences, Inc. is going to release the next earnings report on Nov 14, 2024. Keep track of upcoming events with our Earnings Calendar.
No, KLDO doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, KLDO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Kaleido Biosciences, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Kaleido Biosciences, Inc. technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Kaleido Biosciences, Inc. stock shows the sell signal. See more of Kaleido Biosciences, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.